Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice.

On day 10 after hAMSC treatment, a decreasing trend in TSH was then noted, as usually, the “homing” of exogenous MSCs to the site of injury is limited and does not last for a long time (Montanari et al. 2015 ).

also in 47,180 other papers